Changes of vaginal microbiota during cervical carcinogenesis in women with human papillomavirus infection/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by Claregrieve1 on 2022/10/6

Curated date: 2021/03/21

Curator: Cynthia Anderson

Revision editor(s): WikiWorks, LGeistlinger, Cynthia Anderson, Claregrieve1

Subjects

Location of subjects
South Korea
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Vaginal fluid Vaginal discharge,Vaginal secretion,Vaginal fluid,vaginal fluid
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Cervical glandular intraepithelial neoplasia Cervical glandular intraepithelial neoplasia,cervical glandular intraepithelial neoplasia
Group 0 name Corresponds to the control (unexposed) group for case-control studies
healthy controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
CIN2+/cervical cancer
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
patients with cervical intraepithelial neoplasia 2+ or cervical cancer confirmed by biopsy
Group 0 sample size Number of subjects in the control (unexposed) group
10
Group 1 sample size Number of subjects in the case (exposed) group
20

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Statistical test
Chi-Square
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged

Signature 1

Reviewed Marked as Reviewed by Claregrieve1 on 2022/10/6

Curated date: 2021/03/21

Curator: Cynthia Anderson

Revision editor(s): Cynthia Anderson, Claregrieve1

Source: Table 2

Description: Differential microbial abundance between healthy controls and patients with cervical disease with CIN 2 or 3 and cervical cancer

Abundance in Group 1: increased abundance in CIN2+/cervical cancer

NCBI Quality ControlLinks
Dialister invisus
Fannyhessea vaginae
Finegoldia magna
Gardnerella vaginalis
Hoylesella buccalis
Hoylesella timonensis

Revision editor(s): Cynthia Anderson, Claregrieve1